Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
December 15, 2020Essential Medicines and PatentsMark Schultz and Jaci McDole recently used DrugPatentWatch to complete a report on recent trends in the latest editions of the […]Source0 minPlay
December 03, 2020Drug Patent Expirations for the Week of November 29, 2020PREVEN EMERGENCY CONTRACEPTIVE KIT (ethinyl estradiol; levonorgestrel) Teva branded pharmPatent: 6,156,742Expiration: Dec 5, 2020 See More … For more information […]Source0 minPlay
November 29, 2020New patent expiration for Cubist Pharms drug ENTEREGAnnual Drug Patent Expirations for ENTEREG Entereg is a drug marketed by Cubist Pharms and is included in one NDA. […]Source0 minPlay
November 10, 2020Thinking of signing your company up for DrugPatentWatch?We prefer simple flat-rate unrestricted subscriptions — we’ll work on your terms, and with your favorite subscription contract template, to find […]Source0 minPlay
October 06, 2020Finding and Evaluating Generic Drug Market Entry OpportunitiesHere is a copy of the talk I gave at the recent Marcusevans 13th Portfolio Management and Pipeline Optimization for […]Source0 minPlay
October 06, 2020Freedom of Information Act Access to an Investigational New Drug ApplicationThis article not subject to U.S. Copyright. Published 2019 by the American Chemical Society. Noel T. Southall Abstract We report […]Source0 minPlay
September 24, 2020Finding and Evaluating Generic Market Entry OpportunitiesI’ll be giving a talk on Finding and Evaluating Market Entry Opportunities for a Better ROI at the upcoming 13th […]Source0 minPlay
September 22, 2020Getting the most out of pharmaceutical patent-term extensions in RussiaThis is a guest post by Shamil Gizatullin, Gowling WLG (International) Inc. [email protected] Although it has become harder to obtain […]Source0 minPlay
September 22, 2020Switching to DrugPatentWatchDon’t wait until the end of the year to start looking for alternatives to your existing business intelligence providers. DrugPatentWatch […]Source0 minPlay
September 15, 2020Government as the First Investor in Biopharmaceutical InnovationUsing data from DrugPatentWatch Fred Ledley and his research group at the Center for Integration of Science and Industry at […]Source0 minPlay